Sotabase

Career

· Researcher, MIT Center for Computational Science and Engineering (CCSE)2024–
· Graduate Student, MIT

Publications (16)

LBA55 Primary analysis of a phase II single-arm trial of trastuzumab deruxtecan (T-DXd) in western patients (Pts) with HER2-positive (HER2+) unresectable or metastatic gastric or gastroesophageal junction (GEJ) cancer who progressed on or after a trastuzumab-containing regimen
Annals of Oncology · 2021
43
cited
279P Trastuzumab deruxtecan (T-DXd) in patients with HER2-positive metastatic breast cancer (MBC): Updated survival results from a phase II trial (DESTINY-Breast01)
Annals of Oncology · 2021
37
cited
92O Analysis of study drug-related interstitial lung disease (ILD) in patients (pts) with HER2+ metastatic breast cancer (mBC) treated with trastuzumab deruxtecan (T-DXd)
2021
19
cited
Crystal structure of NE0047 (E143D) mutant in complex with 8-azaguanine
2021
Crystal structure of NE0047 (N66A) mutant in complex with 8-azaguanine
Crystal structure of NE0047 (N66Q) mutant in complex with 8-azaguanine
PMS1 Variables Associated with Choice of Janus Kinase Inhibitors (JAKs) vs Biologics for Treatment of Rheumatoid Arthritis (RA)
2021
PSY14 Disparities in Targeted Immune Modulating (TIM) Treatment for Elderly Compared to Younger Patients with Psoriatic Arthritis (PSA); Observations of US Clinical Practice from Trio Health and the American Rheumatology Network (ARN)
2021
Sotabase